Common Excipients Impair Detection of Protein Aggregates during Sedimentation Velocity Analytical Ultracentrifugation

被引:33
作者
Gabrielson, John P. [1 ,2 ]
Arthur, Kelly K. [1 ]
Kendrick, Brent S. [1 ]
Randolph, Theodore W. [2 ]
Stoner, Michael R. [1 ]
机构
[1] Amgen Inc, Analyt Sci, Longmont, CO 80503 USA
[2] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA
关键词
analytical ultracentrifugation; sedimentation velocity; SEDFIT; protein aggregation; formulation; SIZE-DISTRIBUTION ANALYSIS; FIELD-FLOW FRACTIONATION; MONOCLONAL-ANTIBODY; QUANTITATION; MODEL;
D O I
10.1002/jps.21403
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The final formulations of modern pharmaceutical protein products typically contain sugars or sugar alcohols as stabilizers. Migration of these sugars under the influence of an applied gravitational field during sedimentation velocity analytical ultracentrifugation (SV-AUC) produces dynamic density and viscosity gradients. If the formation of such gradients is not taken into account during data analysis, the capability of the SV-AUC technique to detect protein oligomers/aggregates may be dramatically impacted. In the example described here, the limit of quantitation (LOQ) of a simulated monoclonal antibody (mAb) dimer increases from 0.8% to 2.4% upon addition of 5% sorbitol to the formulation. This study uses simulated and experimental SV-AUC data to demonstrate the detrimental effect of dynamic gradients; it further explores how sophisticated data analysis techniques, including SEDFIT's inhomogeneous solvent options, may be used to mitigate the detection problems caused by the sedimentation of excipients. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:50-62, 2009
引用
收藏
页码:50 / 62
页数:13
相关论文
共 18 条
[1]   Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals [J].
Berkowitz, Steven A. .
AAPS JOURNAL, 2006, 8 (03) :E590-E605
[2]  
Cantor C.R., BIOPHYSICAL CHEM 2
[3]  
Dam J, 2004, METHOD ENZYMOL, V384, P185
[4]  
Durchschlag H., 1986, Thermodynamic Data for Biochemistry and Biotechnology, P45, DOI [10.1007/978-3-642-71114-53, DOI 10.1007/978-3-642-71114-53]
[5]   Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity [J].
Gabrielson, John P. ;
Brader, Mark L. ;
Pekar, Allen H. ;
Mathis, Kathrin B. ;
Winter, Gerhard ;
Carpenter, John F. ;
Randolph, Theodore W. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (02) :268-279
[6]   Sedimentation velocity analytical ultracentrifugation and SEDFIT/c(s):: Limits of quantitation for a monoclonal antibody system [J].
Gabrielson, John P. ;
Randolph, Theodore W. ;
Kendrick, Brent S. ;
Stoner, Michael R. .
ANALYTICAL BIOCHEMISTRY, 2007, 361 (01) :24-30
[7]  
Hearst J E, 1973, Methods Enzymol, V27, P111
[8]   CHARACTERIZATION OF COMPLEX-FORMATION BY HUMANIZED ANTI-IGE MONOCLONAL-ANTIBODY AND MONOCLONAL HUMAN IGE [J].
LIU, J ;
LESTER, P ;
BUILDER, S ;
SHIRE, SJ .
BIOCHEMISTRY, 1995, 34 (33) :10474-10482
[9]   A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation [J].
Liu, Jun ;
Andya, James D. ;
Shire, Steven J. .
AAPS JOURNAL, 2006, 8 (03) :E580-E589
[10]   SIMULATION OF THE TIME COURSE OF MACROMOLECULAR SEPARATIONS IN AN ULTRACENTRIFUGE .1. FORMATION OF A CESIUM-CHLORIDE DENSITY GRADIENT AT 25-DEGREES-C [J].
MINTON, AP .
BIOPHYSICAL CHEMISTRY, 1992, 42 (01) :13-21